A study in humans identified the mir-4729 as a biomarker for recurrent myocardial infarction risk, finding it was downregulated in whole blood of patients with recurrent MI after percutaneous coronary intervention with a false-discovery rate of less than 0.1, though it was not significantly different in plasma samples [Onuoha et al. DOI:10.1111/cts.13307].